Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma

Piotr Damiański, Anna Kumor-Kisielewska, Adam J Białas, Piotr Kuna, Maciej Kupczyk · 2026

Read Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma by Piotr Damiański, Anna Kumor-Kisielewska, Adam J Białas, Piotr Kuna, Maciej Kupczyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479083.txt.

Description

PurposeTo assess the effects of IL-5 pathway inhibition with mepolizumab or benralizumab on circulating eosinophil-related and selected remodeling-associated biomarkers in severe eosinophilic asthma (SEA), and to determine whether these profiles differ according to four-component study-defined early clinical remission (ECR) status.Patients and MethodsThis prospective, observational, single-center cohort study included 30 adults with SEA treated with mepolizumab or benralizumab.

Catalog record

CREATORPiotr Damiański, Anna Kumor-Kisielewska, Adam J Białas, Piotr Kuna, Maciej Kupczyk
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13479083

Browse the full library · About the Tower of Babel